Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AiFame is a Beijing-based biotechnology company specializing in AI-driven protein design and synthetic biology. The company leverages a proprietary computational platform that integrates deep learning with high-throughput experimental data to engineer novel proteins and enzymes with optimized properties. AiFame's technology is designed to accelerate the discovery of biologics for therapeutic areas such as oncology and metabolic diseases, while also developing high-performance biocatalysts for industrial applications. By bridging the gap between digital design and biological function, the company aims to streamline the development of next-generation protein-based products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AiFame.